It is time to reconsider leukoreduction of whole blood for use in patients with life-threatening hemorrhage

Affiliations

• ¹ Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
• ² Canadian Forces Health Services, Ottawa, Ontario, Canada.
• ³ Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
• ⁴ Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, Maryland, USA.
• ⁵ Department of Medicine, Uniformed Services University, Bethesda, Maryland, USA.
• ⁶ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
• ⁷ Association for the Advancement of Blood and Biotherapies (AABB), Bethesda, Maryland, USA.
• ⁸ Department of Surgery, Brook Army Medical Center, San Antonio, Texas, USA.
• ⁹ ImpactLife, Davenport, Iowa, USA.
• ¹⁰ Department of Pathology, St. Louis University School of Medicine, St. Louis, Missouri, USA.
• ¹¹ Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
• ¹² Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.